← Leaderboards
Mythreye Karthikeyan
University Of Alabama At Birmingham
$3,883,444
Attributed
$5,434,389
Total exposure
5
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $798.5K · FY2016–25$1M$750K$500K$250K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,434,389 · 5
By mechanism
R01$3,814,858 · 2
P20$657,481 · 1
T32$562,050 · 1
R41$400,000 · 1
Top collaborators
- Nadine Hempel6 shared
- Rakesh Pravinchandra Patel2 shared
- Mengqian Chen1 shared
Most similar at University Of Alabama At Birmingham
Same institution · by research overlap
- Susan L Bellis$9,674,683
- Sham S Kakar$3,461,583
- Chander Raman$3,569,191
Others in their field
Top investigators on “Neoplastic Cell”
- David Heimbrook · Leidos Biomedical Research, Inc.$139,710,838
- Gregory H Reaman · National Childhood Cancer Foundation$31,993,642
- Bruce W Stillman · Cold Spring Harbor Laboratory$25,455,900
- Ralph Parchment · Leidos Biomedical Research, Inc.$25,266,647
- Andrea Califano · Columbia University Health Sciences$22,374,316
- Wendell A Lim · University Of California, San Francisco$22,334,734
Research focus
Neoplastic CellTargeted TreatmentNeoplasm MetastasisMediatingSignal TransductionIn VitroIn VivoTumor ProgressionCancer CellPathway InteractionsTumor GrowthXenograft ProcedureMalignant Neoplasm Of OvaryMalignant Female Reproductive System NeoplasmMalignant NeoplasmsCancer ModelTumorTherapeutic TargetTranscription FactorGrowth FactorExhibitsPromoterBaseGenes
Grant awards (18)
Nanoparticle formulation of Mediator kinase inhibitor for the treatment of peritoneal ovarian cancer$400,000
R41 · FY2025 · CA
UAB Predoctoral Training Grant in Translational and Molecular Sciences$276,852
T32 · FY2025 · GM
UAB Predoctoral Training Grant in Translational and Molecular Sciences$285,198
T32 · FY2024 · GM
Role of Sox2 in Stress Adaptations to Ovarian Cancer Anchorage Independence$415,290
R01 · FY2023 · CA
Inhibin function in tumor angiogenesis$335,484
R01 · FY2023 · CA · contact PI
Role of Sox2 in Stress Adaptations to Ovarian Cancer Anchorage Independence$408,651
R01 · FY2022 · CA
Inhibin function in tumor angiogenesis$335,484
R01 · FY2022 · CA · contact PI
Role of Sox2 in Stress Adaptations to Ovarian Cancer Anchorage Independence$370,349
R01 · FY2021 · CA
Inhibin function in tumor angiogenesis$342,331
R01 · FY2021 · CA · contact PI
Role of Sox2 in Stress Adaptations to Ovarian Cancer Anchorage Independence$85,812
R01 · FY2021 · CA
Role of Sox2 in Stress Adaptations to Ovarian Cancer Anchorage Independence$424,637
R01 · FY2020 · CA
Role of Sox2 in Stress Adaptations to Ovarian Cancer Anchorage Independence$435,101
R01 · FY2019 · CA
Inhibin function in tumor angiogenesis$316,893
R01 · FY2019 · CA · contact PI
Inhibin function in tumor angiogenesis$8,724
R01 · FY2019 · CA · contact PI
Inhibin function in tumor angiogenesis$336,102
R01 · FY2018 · CA · contact PI
Inhibitors of b-arrestin$224,250
P20 · FY2018 · GM · contact PI
Inhibitors of b-arrestin$226,274
P20 · FY2017 · GM · contact PI
Inhibitors of b-arrestin$206,957
P20 · FY2016 · GM · contact PI